Yoran M Hummel Selected Research

Aftercare (After-Treatment)

1/2020

Long-term survivors of early breast cancer treated with chemotherapy are characterized by a pro-inflammatory biomarker profile compared to matched controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoran M Hummel Research Topics

Disease

9	Heart Failure 01/2020 - 03/2010
6	Left Ventricular Dysfunction 01/2018 - 01/2011
4	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2017
4	ST Elevation Myocardial Infarction 05/2019 - 08/2010
3	Critical Illness (Critically Ill) 01/2019 - 09/2017
3	Pulmonary Hypertension 11/2017 - 10/2015
2	Necrosis 01/2020 - 01/2020
2	Hypovolemia 01/2018 - 09/2013
2	Atrial Fibrillation 12/2017 - 01/2017
2	Myocardial Infarction 01/2016 - 08/2010
1	Cardiotoxicity 01/2020
1	Hypertrophy 01/2020
1	Reperfusion Injury 05/2019
1	Diabetes Mellitus 01/2018
1	Glucose Intolerance 01/2018
1	Atrial Remodeling 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Stroke (Strokes) 01/2015
1	Inflammation (Inflammations) 08/2014
1	Channelopathies 10/2013
1	Brugada Syndrome 10/2013
1	Long QT Syndrome 10/2013
1	Infarction (Infarctions) 08/2010
1	Hypertension (High Blood Pressure) 02/2010

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2017
3	Advanced Glycation End ProductsIBA 08/2011 - 03/2010
2	Angiotensin Receptor AntagonistsIBA 01/2020 - 02/2010
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 08/2011
2	Metformin (Glucophage)FDA LinkGeneric 05/2019 - 01/2016
2	Sildenafil Citrate (Viagra)FDA Link 01/2017 - 10/2015
2	alagebriumIBA 08/2011 - 03/2010
1	Proprotein Convertase 9IBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	LigandsIBA 01/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020
1	AnthracyclinesIBA 01/2020
1	P-SelectinIBA 01/2020
1	CXC ChemokinesIBA 01/2020
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2020
1	Growth Differentiation Factor 15IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	Carbon DioxideIBA 11/2017
1	Natriuretic PeptidesIBA 01/2017
1	pro-brain natriuretic peptide (1-76)IBA 01/2017
1	von Willebrand FactorIBA 08/2014
1	CytokinesIBA 08/2014
1	Endothelins (Endothelin)IBA 08/2014
1	PTX3 proteinIBA 08/2014
1	Peroxidase (Myeloperoxidase)IBA 08/2014
1	Complement C3 (C3 Complement)IBA 08/2014
1	Interleukin-6 (Interleukin 6)IBA 08/2014
1	C-Reactive ProteinIBA 08/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2014
1	SodiumIBA 10/2013
1	Sodium Channels (Sodium Channel)IBA 10/2013
1	ElectrolytesIBA 10/2012
1	AcidsIBA 10/2012
1	Oxygen (Dioxygen)IBA 01/2011
1	eprosartan (Teveten)FDA Link 02/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2010

Therapy/Procedure

4	Renal Dialysis (Hemodialysis) 01/2018 - 10/2012
3	Radiotherapy 01/2020 - 01/2017
3	Critical Care (Surgical Intensive Care) 01/2019 - 09/2017
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2017
2	Percutaneous Coronary Intervention 01/2016 - 08/2010
1	Aftercare (After-Treatment) 01/2020
1	Therapeutics 01/2020
1	Surgical Amputation (Amputations) 01/2015